Identification of cross-reactive CD8+ T cell receptors with high functional avidity to a SARS-CoV-2 immunodominant epitope and its natural mutant variants

Zhou, 2020, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, 579, 270, 10.1038/s41586-020-2012-7 Dong, 2020, An interactive web-based dashboard to track COVID-19 in real time, Lancet Infect Dis, 20, 533, 10.1016/S1473-3099(20)30120-1 Korber, 2020, Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus, Cell, 182, 812, 10.1016/j.cell.2020.06.043 Wise, 2020, Covid-19: new coronavirus variant is identified in UK, BMJ, 371, m4857, 10.1136/bmj.m4857 Chandrashekar, 2020, SARS-CoV-2 infection protects against rechallenge in rhesus macaques, Science, 369, 812, 10.1126/science.abc4776 Corbett, 2020, Evaluation of the mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates, N Engl J Med, 383, 1544, 10.1056/NEJMoa2024671 Mercado, 2020, Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques, Nature, 586, 583, 10.1038/s41586-020-2607-z Gao, 2020, Development of an inactivated vaccine candidate for SARS-CoV-2, Science, 369, 77, 10.1126/science.abc1932 Hoffmann, 2020, A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells, Mol Cell, 78, 779, 10.1016/j.molcel.2020.04.022 Walls, 2020, Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein, Cell, 181, 281, 10.1016/j.cell.2020.02.058 Cao, 2020, Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients' B cells, Cell, 182, 73, 10.1016/j.cell.2020.05.025 Shi, 2020, A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2, Nature, 584, 120, 10.1038/s41586-020-2381-y Ju, 2020, Human neutralizing antibodies elicited by SARS-CoV-2 infection, Nature, 584, 115, 10.1038/s41586-020-2380-z Chen, 2020, Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor, Cell Mol Immunol, 17, 647, 10.1038/s41423-020-0426-7 Grifoni, 2020, Targets of T Cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals, Cell, 181, 1489, 10.1016/j.cell.2020.05.015 Le Bert, 2020, SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls, Nature, 584, 457, 10.1038/s41586-020-2550-z Weiskopf, 2020, Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome, Sci Immunol, 5, eabd2071, 10.1126/sciimmunol.abd2071 Ni, 2020, Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals, Immunity, 52, 971, 10.1016/j.immuni.2020.04.023 Shomuradova, 2020, SARS-CoV-2 epitopes are recognized by a public and diverse repertoire of human T cell receptors, Immunity, 53, 1245, 10.1016/j.immuni.2020.11.004 Yu, 2020, DNA vaccine protection against SARS-CoV-2 in rhesus macaques, Science, 369, 806, 10.1126/science.abc6284 Corbett, 2020, SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness, Nature, 586, 567, 10.1038/s41586-020-2622-0 Peng, 2020, Broad and strong memory CD4(+) and CD8(+) T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19, Nat Immunol, 21, 1336, 10.1038/s41590-020-0782-6 Ferretti, 2020, Unbiased screens show CD8(+) T cells of COVID-19 patients recognize shared epitopes in SARS-CoV-2 that largely reside outside the spike protein, Immunity, 53, 1095, 10.1016/j.immuni.2020.10.006 Chour, 2020 Nelde, 2021, SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition, Nat Immunol, 22, 74, 10.1038/s41590-020-00808-x Poran, 2020, Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes, Genome Med, 12, 70, 10.1186/s13073-020-00767-w Snyder, 2020 Ferretti, 2020 Braun, 2020, SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19, Nature, 587, 270, 10.1038/s41586-020-2598-9 Sekine, 2020, Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19, Cell, 183, 158, 10.1016/j.cell.2020.08.017 Thieme, 2020, Robust T cell response toward spike, membrane, and nucleocapsid SARS-CoV-2 proteins is not associated with recovery in critical COVID-19 patients, Cell Rep Med, 1, 100092, 10.1016/j.xcrm.2020.100092 Kared, 2021, SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals, J Clin Invest, 131, e145476, 10.1172/JCI145476 Lyons, 2006, Influence of human CD8 on antigen recognition by T-cell receptor-transduced cells, Cancer Res, 66, 11455, 10.1158/0008-5472.CAN-06-2379 Tan, 2017, Human leucocyte antigen class I-redirected anti-tumour CD4(+) T cells require a higher T cell receptor binding affinity for optimal activity than CD8(+) T cells, Clin Exp Immunol, 187, 124, 10.1111/cei.12828 Campillo-Davo, 2020, The quest for the best: how TCR affinity, avidity, and functional avidity affect TCR-engineered T-cell antitumor responses, Cells, 9, 1720, 10.3390/cells9071720 Chheda, 2018, Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy, J Exp Med, 215, 141, 10.1084/jem.20171046 He, 2018, HLA common and well-documented alleles in China, HLA, 92, 199, 10.1111/tan.13358 Weiskopf, 2013, Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells, Proc Natl Acad Sci U S A, 110, E2046, 10.1073/pnas.1305227110 Sachs, 2019, Long-term expanding human airway organoids for disease modeling, EMBO J, 38, e100300, 10.15252/embj.2018100300 Jurtz, 2017, NetMHCpan-4.0: improved peptide-MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data, J Immunol, 199, 3360, 10.4049/jimmunol.1700893 Ahmed, 2020, Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies, Viruses, 12, 254, 10.3390/v12030254 Grifoni, 2020, A sequence homology and bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2, Cell Host Microbe, 27, 671, 10.1016/j.chom.2020.03.002 Simon, 2014, Functional TCR retrieval from single antigen-specific human T cells reveals multiple novel epitopes, Cancer Immunol Res, 2, 1230, 10.1158/2326-6066.CIR-14-0108 Hamana, 2016, A novel, rapid and efficient method of cloning functional antigen-specific T-cell receptors from single human and mouse T-cells, Biochem Biophys Res Commun, 474, 709, 10.1016/j.bbrc.2016.05.015 Brochet, 2008, IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis, Nucleic Acids Res, 36, W503, 10.1093/nar/gkn316 Jin, 2018, Engineered T cells targeting E7 mediate regression of human papillomavirus cancers in a murine model, JCI insight, 3, e99488, 10.1172/jci.insight.99488 Cohen, 2006, Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability, Cancer Res, 66, 8878, 10.1158/0008-5472.CAN-06-1450 Jin, 2012, Simplified method of the growth of human tumor infiltrating lymphocytes in gas-permeable flasks to numbers needed for patient treatment, J Immunother, 35, 283, 10.1097/CJI.0b013e31824e801f Zhao, 2020, The 2019 novel coronavirus resource, Yi Chuan, 42, 212 Tan, 2015, T cell receptor binding affinity governs the functional profile of cancer-specific CD8+ T cells, Clin Exp Immunol, 180, 255, 10.1111/cei.12570 Zhong, 2013, T-cell receptor affinity and avidity defines antitumor response and autoimmunity in T-cell immunotherapy, Proc Natl Acad Sci U S A, 110, 6973, 10.1073/pnas.1221609110 Oren, 2014, Functional comparison of engineered T cells carrying a native TCR versus TCR-like antibody-based chimeric antigen receptors indicates affinity/avidity thresholds, J Immunol, 193, 5733, 10.4049/jimmunol.1301769 Schmid, 2010, Evidence for a TCR affinity threshold delimiting maximal CD8 T cell function, J Immunol, 184, 4936, 10.4049/jimmunol.1000173 Villa, 2021, Animal and human RNA viruses: genetic variability and ability to overcome vaccines, Arch Microbiol, 203, 443, 10.1007/s00203-020-02040-5 Duffy, 2018, Why are RNA virus mutation rates so damn high?, PLoS Biol, 16, e3000003, 10.1371/journal.pbio.3000003 Channappanavar, 2014, Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection, J Virol, 88, 11034, 10.1128/JVI.01505-14 Zhao, 2010, T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice, J Virol, 84, 9318, 10.1128/JVI.01049-10 Yang, 2020, A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity, Nature, 586, 572, 10.1038/s41586-020-2599-8 Keech, 2020, Phase 1-2 trial of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine, N Engl J Med, 383, 2320, 10.1056/NEJMoa2026920 Zhu, 2020, Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial, Lancet, 395, 1845, 10.1016/S0140-6736(20)31208-3